Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of May 2019, with a specific transaction notification dated May 23, 2019. The report discloses a transaction involving a Person Discharging Managerial Responsibilities (PDMR), Ms. D. Conrad, Senior Vice President of Human Resources.
Key Financial Metrics
This filing is a transaction notification and does not contain consolidated financial statements. Therefore, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
- Transaction Type: Exercise of share options followed by immediate sale of shares.
- Instrument: Ordinary shares of 25 pence each (ISIN: GB0009252882).
- Volume: 12,650 shares.
- Exercise Price: £12.035 per share.
- Sale Price: £15.892 per share.
- Transaction Date: May 23, 2019.
- Exchange: London Stock Exchange (XLON).
Material Changes
The filing does not report material changes to the company's financial position or operations. It solely documents a routine insider transaction under the GlaxoSmithKline Share Option Plan granted on February 22, 2010.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a regulatory disclosure of a specific securities transaction.
Key Facts for Investor Verification
- Verify the identity and role of Ms. D. Conrad as SVP, Human Resources.
- Confirm the share option grant date of February 22, 2010, and the exercise price of £12.035.
- Note the immediate sale of the exercised shares at £15.892 on the London Stock Exchange.
- Recognize that this filing does not reflect the company's overall financial performance for the period.